Hepatitis C virus infection and isoniazid hepatotoxicity

Chest. 2007 Aug;132(2):736; author reply 736-7. doi: 10.1378/chest.07-0866.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antitubercular Agents / adverse effects*
  • Antitubercular Agents / therapeutic use
  • Hepatitis C / complications*
  • Humans
  • Isoniazid / adverse effects*
  • Isoniazid / therapeutic use
  • Liver / drug effects*
  • Prognosis
  • Risk Factors
  • Substance-Related Disorders / etiology*
  • Tuberculosis / complications
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Isoniazid